Singh Shawn
Insider CIK 1412071 · VSTA President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN Vistagen Therapeutics, Inc | A Award | 2026-06-30 | 2026-07-02 | 36,818 | $0.19 | $7.0K | 54,846 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2026-04-07 | 2026-04-09 | 3,732 | — | $0 | 3,732 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2026-04-07 | 2026-04-09 | 71,268 | — | $0 | 71,268 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award | 2025-06-30 | 2025-07-01 | 7,541 | $1.70 | $12.8K | 18,028 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2025-06-23 | 2025-06-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award | 2024-06-28 | 2024-07-02 | 4,854 | $2.96 | $14.4K | 10,487 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award deriv | 2024-06-24 | 2024-06-26 | 500,000 | — | $0 | 500,000 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award | 2023-12-29 | 2024-01-03 | 167 | $1.72 | $287 | 5,633 | SEC↗ |
| VTGN Vistagen Therapeutics, Inc | A Award | 2023-06-30 | 2023-07-05 | 167 | $1.59 | $266 | 5,466 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2022-12-30 | 2023-01-03 | 5,000 | $0.09 | $450 | 158,998 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2022-08-17 | 2022-08-18 | 600,000 | $0.17 | $102.0K | 626,234 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2022-06-30 | 2022-07-15 | 5,000 | $0.75 | $3.8K | 153,998 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2022-05-12 | 2022-05-16 | 100,000 | — | $0 | 70,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2022-05-12 | 2022-05-16 | 100,000 | $1.00 | $100.0K | 148,998 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2021-12-31 | 2022-01-03 | 3,623 | $1.66 | $6.0K | 48,998 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2021-06-30 | 2021-07-02 | 5,000 | $1.95 | $9.8K | 45,375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2021-04-23 | 2021-04-27 | 5,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2021-04-23 | 2021-04-27 | 5,000 | $1.50 | $7.5K | 40,375 | SEC↗ |
| VTGN | A Award | 2020-12-31 | 2021-01-04 | 5,000 | $0.45 | $2.3K | 35,375 | SEC↗ |
| VTGN | A Award deriv | 2020-12-30 | 2021-01-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2020-06-30 | 2020-07-01 | 5,000 | $0.45 | $2.3K | 30,375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-28 | 2019-05-28 | 170,000 | — | $0 | 170,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-01-14 | 2019-01-14 | 220,000 | $1.70 | $374.0K | 220,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-01-14 | 2019-01-15 | 3,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-01-14 | 2019-01-15 | 21,250 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-01-14 | 2019-01-15 | 1,125 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-01-14 | 2019-01-15 | 21,250 | $1.50 | $31.9K | 21,250 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-01-14 | 2019-01-15 | 3,000 | $1.50 | $4.5K | 25,375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-01-14 | 2019-01-15 | 1,125 | $1.50 | $1.7K | 22,375 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 3,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 3,000 | — | $0 | 3,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 1,125 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 1,125 | — | $0 | 1,125 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 50,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 21,250 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 21,250 | — | $0 | 21,250 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 5,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 200,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 100,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 175,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-02-02 | 2018-02-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-09-19 | 2017-09-20 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-04-26 | 2017-04-28 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-11-09 | 2016-11-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-06-19 | 2016-06-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2016-02-12 | 2016-02-16 | 5,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2016-02-12 | 2016-02-16 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award | 2016-02-12 | 2016-02-16 | 5,625 | — | $0 | 26,234 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 4,017 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 4,017 | — | $0 | 4,017 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 1,786 | — | $0 | 1,786 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 1,786 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 72,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 72,000 | — | $0 | 72,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 150,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 250,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-09-02 | 2015-09-03 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-01-11 | 2015-01-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 425,000 | — | $0 | 425,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 80,338 | — | $0 | 80,338 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 80,338 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 60,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 425,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 1,000,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 22,500 | — | $0 | 22,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 22,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 35,714 | — | $0 | 35,714 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 35,714 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 40,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | M Exercise deriv | 2013-10-15 | 2013-10-15 | 10,000 | — | $0 | 1,440,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | M Exercise | 2013-10-15 | 2013-10-15 | 10,000 | $0.64 | $6.4K | 312,174 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | M Exercise deriv | 2013-06-27 | 2013-06-27 | 50,000 | — | $0 | 1,450,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | M Exercise | 2013-06-27 | 2013-06-27 | 50,000 | $0.64 | $32.0K | 302,174 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2013-03-03 | 2013-03-05 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2012-12-06 | 2012-12-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award | 2012-12-06 | 2012-12-06 | 100,000 | $0.50 | $50.0K | 252,174 | SEC↗ |